Alcohol
28
6
6
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
3.6%
1 terminated out of 28 trials
92.3%
+5.7% vs benchmark
0%
0 trials in Phase 3/4
42%
5 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 12 completed trials
Clinical Trials (28)
Eye-Tracking Alcohol Warning
Alcohol and Cancer Message Testing Experiment
Flavored Ready-to-Drink Alcohol Restriction in Young Adults: Behavioral and Biomarker Outcomes
Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult Women
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HIV-affected Adolescents and Young Adults in Zambia
Decisions During Drinking
Investigating the Effect of Caffeine and Alcohol on Pupil Dynamics
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Testing Alcohol Cancer Risk Messages
Social Media Psychosocial Support Group in Reducing Alcohol Consumption
Evaluation of a Sexual Violence and Intimate Partner Violence Primary Prevention Program Implemented in Drinking Establishments
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study
Investigating the Effects of Calorie Information and Serving Size of Alcohol Products on Alcohol Consumption.
Social Support Intervention for Addiction Recovery
Tirzepatide for Alcohol Use Disorder
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain